Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Scientist

Protein Science · India · 2025-08-21

Processing Time
166 days
Decision Date
2025-08-21
Location
Tennessee
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research in protein science, specifically uncovering molecular mechanisms and signaling pathways in pediatric cancers. The work focuses on identifying therapeutic targets and developing targeted treatments to improve survival outcomes and reduce healthcare burdens.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The work addresses pediatric cancer, which is a critical medical challenge and a leading cause of death among children in the United States.

2 Well-positioned to Advance the Endeavor Met

The petitioner's publication record, citation impact, and roles as a guest editor and peer reviewer demonstrate their standing in the scientific community.

3 Balance of Interests Met

The petitioner’s specialized expertise in protein science provides a benefit to U.S. biomedical innovation that outweighs the need for labor certification.

Why This Petition Was Approved

The petition was approved based on 13 peer-reviewed journal articles and 193 citations, with three papers in the top 20% of their field. The petitioner also demonstrated influence through 12 peer reviews and service as a guest editor, satisfying all three Dhanasar prongs.

Request for Evidence (RFE)

Successfully Addressed

USCIS issued an RFE on April 17, 2025. The petitioner provided further documentation of their research impact and the national significance of their oncology work, resulting in an approval on August 21, 2025.

RFE Targets
Substantial Merit and National ImportanceWell-positioned to Advance the EndeavorBalance of Interests

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Original Contributions
Judging Experience

Similar Cases

Others

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 318 days 2025-12-12
The petitioner proposes to use small molecules in proteomic and multi-omic techniques to advance the understanding of cancer-relevant molecular pathways. This work focuses on identifying and characterizing mechanisms central to disease progression to support basic cancer research and treatment development.
View Case

Research Fellow

Biotechnology · Brazil

WeGreened EB-2 (NIW) approved
Maryland 65 days 2022-04-14
The petitioner proposes to continue investigating RNA and RNA-binding proteins implicated in cancer initiation and development. The work focuses on advancing cancer treatment, diagnosis, and prognosis by providing alternative treatments to chemotherapy, radiation, and surgery.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Others

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-08-21.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 166 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist